Last reviewed · How we verify
NCT03924141
Evaluation of Training in De-escalation
NA trial testing Training in de-escalation in De-escalation Skills in 45 participants. Completed in 30 June 2020.
26 November 2019
Quick facts
| Lead sponsor | Bergen University College |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 45 |
| Start date | 18 February 2019 |
| Primary completion | 26 November 2019 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Training in de-escalation
Conditions studied
- De-escalation Skills — all drugs for De-escalation Skills →
Sponsor
Bergen University College
Who can join
Adults 18 to 60, any sex, with De-escalation Skills. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate one of the chapters in the new national Norwegian training manual (MAP). The chapter that is selected to be evaluated is the chapter on de-escalation. Effective training in this topic should not only lead to changes in the level of knowledge and attitudes, but also changes in behavior and skills. Experiencing better preparedness does not necessarily entail a change in behavior. This study wants to test whether training in de-escalation changes the participants' skills and experience of self-confidence, security and coping in threatening situations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03924141
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bergen University College trials
Trials by the same sponsor.
- NCT04076384 — Effectiveness of a Team-based Follow-up Program in General Practice Among People With Chronic Conditions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03924141 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bergen University College
- Last refreshed: 5 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03924141.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing